Canagliflozin and risk of amputation in patients with type 2 diabetes

Sodium glucose co-transporter type 2 inhibitors (SGLT2) are a new effective group of oral hypoglygemic drugs for the treatment of diabetes type 2.At Door Decorations the moment there is no unanimous opinion on their safety.The article presents the data on clinical studies CANVAS and CANVAS-R and reports of the international database VigiBase (2015 - 2017) on the risk of amputation Eye in patients with type 2 diabetes undergoing treatment with canagliflozin.